Skip to main content

Advertisement

Log in

Prenotification and Other Factors Involved in Rapid tPA Administration

  • Cardiovascular Disease and Stroke (D Leifer and JE Safdieh, Section Editors)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

In acute ischemic stroke, time is brain. Current guidelines recommend that the time from arrival at hospital to initiation of administration of tissue plasminogen activator, also known as the door-to-needle (DTN) time, should be 60 min or less. However, DTN times in practice usually exceed this recommended time. The median DTN times from the American Heart Association/American Stroke Association Get With The Guidelines-Stroke program and the multinational Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register are 75 min and 65 min, respectively. Prehospital factors associated with delays include patient-related factors such as poor recognition of stroke symptoms, poor use of emergency medical services, and complex psychosocial factors. Accurate recognition of stroke symptoms at a dispatcher and paramedic level is associated with shorter onset-to-arrival times. Prenotification of regional stroke centers by paramedics is strongly associated with shorter DTN times. In-hospital delays resulting in prolonged DTN times can be attenuated by having well-defined rapid triage pathways, defined stroke teams, single-call stroke team activation, established code stroke protocols, rapid access to diagnostic imaging, and laboratory services. In this review we summarize factors associated with prolonged DTN times and processes that allow faster onset-to-treatment times. Recent developments in the field are highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Saver JL. Time is brain–quantified. Stroke. 2006;37(1):263–6.

    Article  PubMed  Google Scholar 

  2. Vergouwen MD, Algra A, Pfefferkorn T, et al. Time is brain(stem) in basilar artery occlusion. Stroke. 2012;43(11):3003–6.

    Article  PubMed  Google Scholar 

  3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. New Engl J Med. 1995;333(24):1581–7.

    Google Scholar 

  4. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379(9834):2364–72.

    Article  PubMed  CAS  Google Scholar 

  5. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9727):1695–703.

    Article  PubMed  CAS  Google Scholar 

  6. •• Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79(4):306–13. This article demonstrates the value of using multiple concurrent strategies to reduce DTN times to 20 min.

    Article  PubMed  Google Scholar 

  7. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283(23):3102–9.

    Article  PubMed  CAS  Google Scholar 

  8. Adams Jr HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(20):e478–534.

    Article  PubMed  Google Scholar 

  9. Summers D, Leonard A, Wentworth D, et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke. 2009;40(8):2911–44.

    Article  PubMed  Google Scholar 

  10. •• Fonarow GC, Smith EE, Saver JL, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011;42(10):2983–9. The AHA/ASA Target: Stroke initiative is a national quality improvement program designed to facilitate implementation of best practices for rapid, safe delivery of thrombolysis. This article outlines time-based tPA treatment related goals and suggests mechanisms to achieve them.

    Article  PubMed  Google Scholar 

  11. Smith EE, von Kummer R. Door-to-needle times in acute ischemic stroke: how low can we go? Neurology. 2012;79(4):296–7.

    Article  PubMed  Google Scholar 

  12. Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3–4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866–74.

    Article  PubMed  CAS  Google Scholar 

  13. •• Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123(7):750–8. This article examines the timeliness of tPA administration and factors that result in delay in the largest analysis of its kind of the GWTG-Stroke database. It demonstrates that only a minority of patients are treated within the prescribed 60-min window from arrival at hospital.

    Article  PubMed  CAS  Google Scholar 

  14. Messe SR, Fonarow GC, Smith EE, et al. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes. 2012;5(3):321–6.

    Article  PubMed  Google Scholar 

  15. Nadeau JO, Shi S, Fang J, et al. TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci. 2005;32(4):433–9.

    PubMed  Google Scholar 

  16. Evenson KR, Foraker RE, Morris DL, Rosamond WD. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke. 2009;4(3):187–99.

    Article  PubMed  CAS  Google Scholar 

  17. Mackintosh JE, Murtagh MJ, Rodgers H, Thomson RG, Ford GA, White M. Why people do, or do not, immediately contact emergency medical services following the onset of acute stroke: qualitative interview study. PloS One. 2012;7(10):e46124.

    Article  PubMed  CAS  Google Scholar 

  18. • Lecouturier J, Murtagh MJ, Thomson RG, et al. Response to symptoms of stroke in the UK: a systematic review. BMC Health Serv Res. 2010;10:157. This article highlights patient factors resulting in OTA delays.

    Article  PubMed  Google Scholar 

  19. Salisbury HR, Banks BJ, Footitt DR, Winner SJ, Reynolds DJ. Delay in presentation of patients with acute stroke to hospital in Oxford. QJM. 1998;91(9):635–40.

    Article  PubMed  CAS  Google Scholar 

  20. Giles MF, Flossman E, Rothwell PM. Patient behavior immediately after transient ischemic attack according to clinical characteristics, perception of the event, and predicted risk of stroke. Stroke. 2006;37(5):1254–60.

    Article  PubMed  Google Scholar 

  21. Shah M, Makinde KA, Thomas P. Cognitive and behavioral aspects affecting early referral of acute stroke patients to hospital. J Stroke Cerebrovasc Dis. 2007;16(2):71–6.

    Article  PubMed  Google Scholar 

  22. Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke. 1992;23(3):352–6.

    Article  PubMed  CAS  Google Scholar 

  23. Teuschl Y, Brainin M. Stroke education: discrepancies among factors influencing prehospital delay and stroke knowledge. Int J Stroke. 2010;5(3):187–208.

    Article  PubMed  Google Scholar 

  24. Dombrowski SU, Sniehotta FF, Mackintosh J, et al. Witness response at acute onset of stroke: a qualitative theory-guided study. PloS One. 2012;7(7):e39852.

    Article  PubMed  CAS  Google Scholar 

  25. Deakin CD, Alasaad M, King P, Thompson F. Is ambulance telephone triage using advanced medical priority dispatch protocols able to identify patients with acute stroke correctly? Emerg Med J. 2009;26(6):442–5.

    Article  PubMed  CAS  Google Scholar 

  26. Ramanujam P, Guluma KZ, Castillo EM, et al. Accuracy of stroke recognition by emergency medical dispatchers and paramedics—San Diego experience. Prehosp Emerg Care. 2008;12(3):307–13.

    Article  PubMed  Google Scholar 

  27. Krebes S, Ebinger M, Baumann AM, et al. Development and validation of a dispatcher identification algorithm for stroke emergencies. Stroke. 2012;43(3):776–81.

    Article  PubMed  Google Scholar 

  28. Bray JE, Martin J, Cooper G, Barger B, Bernard S, Bladin C. An interventional study to improve paramedic diagnosis of stroke. Prehosp Emerg Care. 2005;9(3):297–302.

    Article  PubMed  Google Scholar 

  29. Govindarajan P, Ghilarducci D, McCulloch C, Pierog J, Bloom E, Johnston C. Comparative evaluation of stroke triage algorithms for emergency medical dispatchers (MeDS): prospective cohort study protocol. BMC Neurol. 2011;11:14.

    Article  PubMed  Google Scholar 

  30. Mosley I, Nicol M, Donnan G, Patrick I, Kerr F, Dewey H. The impact of ambulance practice on acute stroke care. Stroke. 2007;38(10):2765–70.

    Article  PubMed  Google Scholar 

  31. Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke. 2005;36(7):1512–8.

    Article  PubMed  Google Scholar 

  32. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke. 2000;31(1):71–6.

    Article  PubMed  CAS  Google Scholar 

  33. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33(4):373–8.

    Article  PubMed  CAS  Google Scholar 

  34. Gladstone DJ, Rodan LH, Sahlas DJ, et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009;40(12):3841–4.

    Article  PubMed  CAS  Google Scholar 

  35. Schwamm LH, Pancioli A, Acker 3rd JE, et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation. 2005;111(8):1078–91.

    Article  PubMed  Google Scholar 

  36. •• Tong D, Reeves MJ, Hernandez AF, et al. Times from symptom onset to hospital arrival in the Get With The Guidelines–Stroke program 2002 to 2009: temporal trends and implications. Stroke. 2012;43(7):1912–7. This review of the GWTG-Stroke database outlines factors responsible for delays in onset-to-treatment times and highlights the lack of improvement in OTA times over the study period. Use of EMS, daytime stroke, and higher stroke severity result in shorter OTA times.

    Article  PubMed  Google Scholar 

  37. • Addo J, Ayis S, Leon J, Rudd AG, McKevitt C, Wolfe CD. Delay in presentation after an acute stroke in a multiethnic population in south London: the South London Stroke Register. J Am Heart Assoc. 2012;1(3):e001685. This article considers the factors related to OTA delays in a multiethnic European population.

  38. Maestroni A, Mandelli C, Manganaro D, et al. Factors influencing delay in presentation for acute stroke in an emergency department in Milan. Italy Emerg Med J. 2008;25(6):340–5.

    Article  CAS  Google Scholar 

  39. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke. 2000;31(11):2585–90.

    Article  PubMed  CAS  Google Scholar 

  40. Wojner AW, Morgenstern L, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Paramedic and emergency department care of stroke: baseline data from a citywide performance improvement study. Am J Crit Care. 2003;12(5):411–7.

    PubMed  Google Scholar 

  41. Kim SK, Lee SY, Bae HJ, et al. Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke. Eur J Neurol. 2009;16(12):1331–5.

    Article  PubMed  CAS  Google Scholar 

  42. • Lin CB, Peterson ED, Smith EE, et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2012;5(4):514–22. This is one of several articles demonstrating the strong association between hospital prenotification by EMS and shorter DTN times.

    Article  PubMed  Google Scholar 

  43. •• McKinney JS, Mylavarapu K, Lane J, Roberts V, Ohman-Strickland P, Merlin MA. Hospital prenotification of stroke patients by emergency medical services improves stroke time targets. J Stroke Cerebrovasc Dis. 2013;22(2):113–8. This is one of several articles demonstrating the strong association between hospital prenotification by EMS and shorter DTN times.

    Article  PubMed  Google Scholar 

  44. Acker 3rd JE, Pancioli AM, Crocco TJ, et al. Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke. 2007;38(11):3097–115.

    Article  PubMed  Google Scholar 

  45. Crocco TJ, Grotta JC, Jauch EC, et al. EMS management of acute stroke–prehospital triage (resource document to NAEMSP position statement). Prehosp Emerg Care. 2007;11(3):313–7.

    Article  PubMed  CAS  Google Scholar 

  46. European Stroke Organisation Executive C, Committee ESOW. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507.

    Article  Google Scholar 

  47. •• Lin CB, Peterson ED, Smith EE, et al. Patterns, predictors, variations, and temporal trends in emergency medical service hospital prenotification for acute ischemic stroke. J Am Heart Assoc. 2012;1(4):e002345. This is one of several articles demonstrating the strong association between hospital prenotification by EMS and shorter DTN times. In addition, the authors examine the factors related to prenotification by EMS in the large GWTG-Stroke database.

    Article  PubMed  Google Scholar 

  48. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283(9):1145–50.

    Article  PubMed  CAS  Google Scholar 

  49. Mikulik R, Kadlecova P, Czlonkowska A, et al. Factors influencing in-hospital delay in treatment with intravenous thrombolysis. Stroke. 2012;43(6):1578–83.

    Article  PubMed  Google Scholar 

  50. Saver JL, Smith EE, Fonarow GC, et al. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010;41(7):1431–9.

    Article  PubMed  Google Scholar 

  51. Kohrmann M, Schellinger PD, Breuer L, et al. Avoiding in hospital delays and eliminating the three-hour effect in thrombolysis for stroke. Int J Stroke. 2011;6(6):493–7.

    Article  PubMed  Google Scholar 

  52. Belvis R, Cocho D, Marti-Fabregas J, et al. Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain. Cerebrovasc Dis. 2005;19(2):96–101.

    Article  PubMed  Google Scholar 

  53. Hill MD, Buchan AM. Canadian Alteplase for Stroke Effectiveness Study I, Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172(10):1307–12.

    PubMed  Google Scholar 

  54. de la Ossa NP, Sanchez-Ojanguren J, Palomeras E, et al. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients. Neurology. 2008;70(15):1238–43.

    Article  PubMed  Google Scholar 

  55. Nazir FS, Petre I, Dewey HM. Introduction of an acute stroke team: an effective approach to hasten assessment and management of stroke in the emergency department. J Clin Neurosci. 2009;16(1):21–5.

    Article  PubMed  CAS  Google Scholar 

  56. Hamidon BB, Dewey HM. Impact of acute stroke team emergency calls on in-hospital delays in acute stroke care. J Clin Neurosci. 2007;14(9):831–4.

    Article  PubMed  CAS  Google Scholar 

  57. Tai YJ, Weir L, Hand P, Davis S, Yan B. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis? Intern Med J. 2012;42(12):1316–24.

    Article  PubMed  CAS  Google Scholar 

  58. Mehdiratta M, Woolfenden AR, Chapman KM, et al. Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can J Neurol Sci. 2006;33(2):214–6.

    PubMed  CAS  Google Scholar 

  59. • Nolte CH, Malzahn U, Kuhnle Y, Ploner CJ, Muller-Nordhorn J, Mockel M. Improvement of door-to-imaging time in acute stroke patients by implementation of an all-points alarm. J Stroke Cerebrovasc Dis. 2013;22(2):149–53. This article demonstrates the utility of a single-call activation system in acute stroke.

    Article  PubMed  Google Scholar 

  60. •• Jauch EC, Saver JL, Adams Jr HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. This article provides comprehensive guidelines for management of AIS.

    Article  PubMed  Google Scholar 

  61. Sattin JA, Olson SE, Liu L, Raman R, Lyden PD. An expedited code stroke protocol is feasible and safe. Stroke. 2006;37(12):2935–9.

    Article  PubMed  Google Scholar 

  62. Green TL, Mansoor A, Newcommon N, Stephenson C, Stewart E, Hill MD. Reliability of point-of-care testing of INR in acute stroke. Can J Neurol Sci. 2008;35(3):348–51.

    PubMed  Google Scholar 

  63. Rizos T, Jenetzky E, Herweh C, et al. Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage. Ann Neurol. 2010;67(6):788–93.

    PubMed  Google Scholar 

  64. • Walter S, Kostopoulos P, Haass A, et al. Point-of-care laboratory halves door-to-therapy-decision time in acute stroke. Ann Neurol. 2011;69(3):581–6. Use of point-of-care INR testing when indicated can result in substantial reduction in DTN times as demonstrated in this article..

    Article  PubMed  Google Scholar 

  65. •• Kelly AG, Hellkamp AS, Olson D, Smith EE, Schwamm LH. Predictors of rapid brain imaging in acute stroke: analysis of the Get With the Guidelines-Stroke program. Stroke. 2012;43(5):1279–84. This is the largest study examining factors resulting in short DTI times in the national GWTG-Stroke database.

  66. Rose KM, Rosamond WD, Huston SL, Murphy CV, Tegeler CH. Predictors of time from hospital arrival to initial brain-imaging among suspected stroke patients: the North Carolina Collaborative Stroke Registry. Stroke. 2008;39(12):3262–7.

    Article  PubMed  Google Scholar 

  67. •• Ford AL, Williams JA, Spencer M, et al. Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis. Stroke. 2012;43(12):3395–8. This single-center study demonstrates the usefulness of Toyota's lean manufacturing principles and value stream analysis in identifying institutional inefficiencies in the acute stroke treatment pathway.

  68. Strbian D, Soinne L, Sairanen T, et al. Ultraearly thrombolysis in acute ischemic stroke is associated with better outcome and lower mortality. Stroke. 2010;41(4):712–6.

    Article  PubMed  Google Scholar 

  69. Wolfe F, Michaud K. The Hawthorne effect, sponsored trials, and the overestimation of treatment effectiveness. J Rheumatol. 2010;37(11):2216–20.

    Article  PubMed  Google Scholar 

  70. Qureshi AI, Suri MF, Nasar A, et al. Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999–2001. Neurosurgery. 2005;57(4):647–54. discussion 647–54.

    Article  PubMed  Google Scholar 

  71. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39(3):924–8.

    Article  PubMed  Google Scholar 

  72. Kostopoulos P, Walter S, Haass A, et al. Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology. 2012;78(23):1849–52.

    Article  PubMed  CAS  Google Scholar 

  73. Liman TG, Winter B, Waldschmidt C, et al. Telestroke ambulances in prehospital stroke management: concept and pilot feasibility study. Stroke. 2012;43(8):2086–90.

    Article  PubMed  Google Scholar 

  74. •• Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol. 2012;11(5):397–404. This article, as well as [75••], represents a radical rethinking of how to achieve a significant reduction in DTN times by bringing tPA treatment by ambulance to the patient in the field, eliminating the time required for transportation to the emergency department.

  75. •• Weber JE, Ebinger M, Rozanski M, et al. Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurol. 2013;80(2):163–8. The authors demonstrate the efficacy and safety of point-of-emergency thrombolysis in the field, prior to transport to the emergency department.

Download references

Conflicts of Interest

Jamsheed A. Desai declares no conflicts of interest.

Eric E. Smith declares no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric E. Smith.

Additional information

This article is part of the Topical Collection on Cardiovascular Disease and Stroke

Rights and permissions

Reprints and permissions

About this article

Cite this article

Desai, J.A., Smith, E.E. Prenotification and Other Factors Involved in Rapid tPA Administration. Curr Atheroscler Rep 15, 337 (2013). https://doi.org/10.1007/s11883-013-0337-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-013-0337-5

Keywords

Navigation